Cost-effectiveness of office-based buprenorphine treatment for opioid use disorder.

ABSTRACT:

Aim

To assess the effectiveness and cost-effectiveness of office-based buprenorphine treatment (OBBT) in the U.S.

Design setting and participants

We performed a model-based analysis of buprenorphine treatment provided in a primary care setting for the U.S. population with OUD.

Intervention

Buprenorphine treatment provided in a primary care setting.

Measurements

Fatal and nonfatal overdoses and deaths over five years, discounted lifetime quality-adjusted life years (QALYs), costs.

Findings

For a cohort of 100,000 untreated individuals who enter OBBT, approximately 9350 overdoses would be averted over five years; of these, approximately 900 would have been fatal. OBBT compared to no treatment would yield 1.07 incremental lifetime QALYs per person at an inc

SUBMITTER: Qian G 

PROVIDER: S-EPMC9852082 | biostudies-literature | 2023 Feb

REPOSITORIES: biostudies-literature